Interferon-Based Treatment of Hepatitis C Virus Infection Reduces All-Cause Mortality in Patients With End-Stage Renal Disease: An 8-Year Nationwide Cohort Study in Taiwan

The long-term survival of end-stage renal disease (ESRD) patients with hepatitis C virus (HCV) infection who received interferon treatment has not been extensively evaluated. The HCV cohort was the ESRD patients with de novo HCV infection from 2004 to 2011; they were classified into treated and untr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Yueh-Han, Hung, Peir-Haur, Muo, Chih-Hsin, Tsai, Wen-Chen, Hsu, Chih-Cheng, Kao, Chia-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
4200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058999/
https://www.ncbi.nlm.nih.gov/pubmed/26632730
http://dx.doi.org/10.1097/MD.0000000000002113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058999/
https://www.ncbi.nlm.nih.gov/pubmed/26632730
http://dx.doi.org/10.1097/MD.0000000000002113

Ejemplares similares